Shares of Hologic Inc. HOLX slipped 2.38% to $61.10 Wednesday, on what proved to be an all-around mixed trading session for ...

The stock's fall snapped a three-day winning streak.

A defining moment in women's sports The pioneering initiative, supported by PIF and championed by the WTA Players' Council, ...

The unseeded Madison Keys captured the ninth Hologic WTA Tour title of her career, second in Adelaide (following 2022) and fourth on outdoor hard courts at the 2025 Adelaide International. Keys ...

Hologic, a medical technology company focused on women's health, has promoted an 18-year veteran of its legal department to ...

Argus downgraded Hologic (HOLX) to Hold from Buy.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ...

Jessica Pegula captured her seventh career Hologic WTA Tour singles title at the ATX Open in Austin on Sunday by defeating McCartney Kessler 7-5, 6-2 in an all-American final. Austin: Draws | Scores | ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Hologic, Inc. has a one year low of $62.69 and a one year high of $84.67. The stock has a market capitalization of $14.44 billion, a PE ratio of 20.30, a PEG ratio of 2.14 and a beta of 0.98.

Last week, Hologic HOLX earned two key regulatory approvals. The company’s Affirm Contrast Biopsy software has earned the CE Mark, having previously been cleared by the FDA in October 2020.